Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|June 23, 2016
How Technology is Changing the Specialty Pharmacy Patient Experience
Author(s)Lauren Santye, Assistant Editor
Paul LeVine, vice president of Analytic Services at TrialCard, discusses the use of technology to improve patient care in specialty pharmacy.
Advertisement
Paul LeVine, vice president of Analytic Services at TrialCard, discusses the use of technology to improve patient care in specialty pharmacy.
Advertisement
Related to this article
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Apitegromab-mstn is cleared as an add-on to SMN2-targeted treatment for patients aged 2 and older, directly addressing muscle loss.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5